Neurodegenerative diseases of the retina and potential for protection and recovery
about
Ocular neuroprotection by siRNA targeting caspase-2Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors.The role of peroxisome proliferator-activated receptor and effects of its agonist, pioglitazone, on a rat model of optic nerve crush: PPARγ in retinal neuroprotection.Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers.A method for electrophysiological characterization of hamster retinal ganglion cells using a high-density CMOS microelectrode array.Is Estrogen a Therapeutic Target for Glaucoma?17β-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma.Neuroprotective Effect of Puerarin on Glutamate-Induced Cytotoxicity in Differentiated Y-79 Cells via Inhibition of ROS Generation and Ca(2+) InfluxDeletion of thioredoxin-interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury.Neonatal monosodium glutamate treatment counteracts circadian arrhythmicity induced by phase shifts of the light-dark cycle in female and male Siberian hamsters.Calcium binding protein-mediated regulation of voltage-gated calcium channels linked to human diseases.Glaucomatous optic neuropathy management: the role of neuroprotective agents.Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit.Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity.Isolation of Primary Murine Retinal Ganglion Cells (RGCs) by Flow Cytometry.Morphometric analysis of connective tissue sheaths of sural nerve in diabetic and nondiabetic patientsThe Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.A potential neuroprotective role of apolipoprotein E-containing lipoproteins through low density lipoprotein receptor-related protein 1 in normal tension glaucoma.Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies.Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action.Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes.Glutamate-induced internalization of Ca(v)1.3 L-type Ca(2+) channels protects retinal neurons against excitotoxicity.A capillary fraction collector coupled to a fluorescence reader: a novel device to continuously quantify glutamate during microdialysis.Synthetic conantokin peptides potently inhibit N-methyl-D-aspartate receptor-mediated currents of retinal ganglion cells.Impact of aromatase absence on murine intraocular pressure and retinal ganglion cells.Some Operational Characteristics of Glycine Release in Rat Retina: The Role of Reverse Mode Operation of Glycine Transporter Type-1 (GlyT-1) in Ischemic Conditions.Gonadal Hormones and Retinal Disorders: A Review.The Association between Female Reproductive Factors and Open-Angle Glaucoma in Korean Women: The Korean National Health and Nutrition Examination Survey V
P2860
Q34192944-B20E685B-1DAA-4201-8371-9D5A804643A9Q34571728-4D8C40FB-DB80-4841-8F7A-735734AB425EQ34851916-253F1183-4CD0-4B2E-9C81-4BC2B9DE6CA8Q36117585-29656824-ADD6-4FCF-B04B-FC8B8FD18F4CQ36149694-FC106D92-F073-42EF-B4D5-0979FD3CCB8CQ37059521-0B5E8999-44D6-4244-A1D3-F481C2B4EBDCQ37134516-4946E38C-24A3-4A3D-BD25-812188A02F55Q37134595-3271E98A-5D2A-42B3-BC38-CC8569877B2DQ37635278-C654BD40-6359-4D26-ADF1-71C64B2617DEQ37662306-98156D68-5A72-4667-BA7B-B9D64E0857C8Q37885154-7840997F-1702-4E11-8FDF-3B34146B9FF2Q38193827-B39E0575-B020-4824-95B8-8CA439D5FA98Q38256054-D82711E5-8F8F-4788-B82C-126783771D34Q38387172-FCFADE52-6D4D-4A04-92C0-117350F83758Q38656462-F79E99FB-5BC6-4920-8D69-A995DAC497A6Q39141239-F08F7A2A-2F5E-4641-AF2A-AD1E397189AAQ39227810-DEBF0D18-A9C6-416A-8A7F-8A2B2872DF2FQ42016650-30B11DA0-8049-4981-9FCB-34BDAB235FDEQ42099855-ED10508D-C0FB-4FA0-BBC3-3C0B5B4D4A33Q42120726-CEA2AD41-7C55-4373-B05B-A34543ADBB21Q42470643-5E357471-F1A7-4842-892D-DD24E3D51540Q43177723-3FB312B2-26FA-4CFD-8A41-3D78EAFBDF80Q48624372-122FED92-7BD9-4C86-BF3A-22746DB40FBBQ48648519-0AA2DE3A-A1B2-4250-A53E-D95792857A9BQ49830306-4BF25EB8-ED69-4E66-B1D8-1E6DB4E0A139Q52663498-A49BADFE-945F-4ABD-91B6-3134D5A8CE56Q54990705-7E4E5EBB-CAA8-4483-86D9-0E61D57CE1CEQ57215655-D81BA344-CB39-438F-B7DC-821E69BCF30E
P2860
Neurodegenerative diseases of the retina and potential for protection and recovery
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Neurodegenerative diseases of the retina and potential for protection and recovery
@en
type
label
Neurodegenerative diseases of the retina and potential for protection and recovery
@en
prefLabel
Neurodegenerative diseases of the retina and potential for protection and recovery
@en
P2093
P2860
P1476
Neurodegenerative diseases of the retina and potential for protection and recovery
@en
P2093
K-G Schmidt
R H W Funk
P2860
P304
P356
10.2174/157015908784533851
P577
2008-06-01T00:00:00Z